How many drugs treat Chronic ulcerative proctitis?

Drug Landscape tracks 4 marketed treatments for Chronic ulcerative proctitis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/chronic-ulcerative-proctitis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Chronic ulcerative proctitis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Chronic ulcerative proctitis (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Chronic ulcerative proctitis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Rowasa	Mesalazine	Meda Pharms	Aminosalicylate [EPC]	Prostaglandin G/H synthase 2	1987-01-01
Cortef	hydrocortisone	Generic (originally Merck/Upjohn)	Corticosteroid [EPC]	Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible	1952-01-01
MESA	MESA	Meda Pharms		Arachidonate 5-lipoxygenase, Peroxisome proliferator-activated receptor gamma, Prostaglandin G/H synthase 1
Cortisol	Cortisol	University of Zurich		Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Meda Pharms · 2 drugs in Chronic ulcerative proctitis
· 1 drug in Chronic ulcerative proctitis
Generic (originally Merck/Upjohn) · 1 drug in Chronic ulcerative proctitis
University of Zurich · 1 drug in Chronic ulcerative proctitis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Chronic ulcerative proctitis:

Cite this brief

Drug Landscape (2026). Chronic ulcerative proctitis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/chronic-ulcerative-proctitis. Accessed 2026-06-10.

Chronic ulcerative proctitis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing